Which to choose mid BB or top Rx

Hey monkeys,

I've been fortunate enough to get offers at a mid BB (BAML/Citi/Barclays) and a top Rx shop (HL/PJT). To be honest, I'm not sure what I want to do 5-10 years down the road but think it'll be something on the buy-side. Regardless I'd love some advice with the decision, so I've quickly listed some pros/cons of each place below. Let me know what you think.

mid BB

Pros: - Brand name, especially outside of finance - Large, full-service, maybe opportunities to switch groups if need be - Good culture and got along with the people - M&A (doesn't pigeon hole me like Rx might)

Cons: - Could end up in group I hate or doesn't place well - Bureaucratic - Overstaffed deal-teams - Placement for buy-side gigs(?)

top Rx

Pros: -Great reputation within Rx -Great placement for buy-side gigs -Great culture as well -Rx seems more interesting

Cons: -Will be pigeon-holed for distressed type stuff -Name is probably not super well known outside of finance

13 Comments
 

The RX position sounds like HL. While HL is not as renowned outside of finance/restructuring, I would still choose it over BAML, etc. for the pros and cons you mentioned as well as the current state of the economy. RX is on a upswing, while other products/industries groups are not. The best deal experiences in the next 1-3 years will be in RX.

If RX is PJT (or Lazard, Evercore, etc.), then definitely take RX.

 

How is this even a debate? If it is PJT then answer is obviously PJT. HL if New York maybe could be less than a great group at one of the bulge brackets you mentioned, but if it is an average or below average group at the BB then obviously take HL. You need to accept that if you want a career in this industry nobody is going to know about what you do unless they work in the industry. No girl at a bar is impressed if you work at Lazard or Centerbridge or Trian or whatever, but those are the best places to work. You need to give up on this whole name recognition thing cross industry in my opinion -- if you work for a great shop doing $bn restructurings everyone will respect what you did even if they don't know what Houlihan is.

 

Et est et incidunt nostrum non eos ea. Nisi provident sint quia temporibus debitis quod accusamus. Quis accusamus ipsum beatae asperiores delectus aliquid provident autem.

Career Advancement Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

July 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.8%
  • Morgan Stanley 01 98.3%
  • BMO Capital Markets 13 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • Goldman Sachs 01 97.7%
  • JPMorgan 01 97.1%

Total Avg Compensation

July 2026 Investment Banking

  • Vice President (15) $434
  • Associates (46) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (80) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
kanon's picture
kanon
99.0
4
Secyh62's picture
Secyh62
99.0
5
CompBanker's picture
CompBanker
98.9
6
dosk17's picture
dosk17
98.9
7
DrApeman's picture
DrApeman
98.9
8
GameTheory's picture
GameTheory
98.9
9
Betsy Massar's picture
Betsy Massar
98.9
10
Mimbs's picture
Mimbs
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”